NCT05640232View on ClinicalTrials.gov

Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

June 28, 2026

Study Completion Date

January 30, 2027

Conditions
Primary Dysmenorrhea
Interventions
DRUG

CDE100 association

Experimental drug.

DRUG

Buscopan® Composto association

Active comparator.

Trial Locations (1)

Unknown

Investigational Site, São Paulo

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY